Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic desloratadine 5 mg (DESTA) vs AERIUS in healthy Thai volunteers under fasting conditions
TCTR20220322004Phase 4Completed
- Sponsor
- MacroPhar
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desloratadine in allergic rhinitis (AR), chronic idiopathic urticaria (CIU), sponsored by MacroPhar. Started Oct 2022; status: completed.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on TCTR20220322004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220322004.